Literature DB >> 28456585

Treating head and neck cancer: for better or for worse?

Alex Sklan1, David Collingridge1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28456585     DOI： 10.1016/S1470-2045(17)30269-3

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  4 in total

1.  Impact of double reading on NI-RADS diagnostic accuracy in reporting oral squamous cell carcinoma surveillance imaging - a single-center study.

Authors:  Fabian Henry Jürgen Elsholtz; Sa-Ra Ro; Seyd Shnayien; Patrick Dinkelborg; Bernd Hamm; Lars-Arne Schaafs
Journal:  Dentomaxillofac Radiol       Date:  2021-07-08       Impact factor: 2.419

2.  Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations.

Authors:  Alan L Ho; Irene Brana; Robert Haddad; Jessica Bauman; Keith Bible; Sjoukje Oosting; Deborah J Wong; Myung-Ju Ahn; Valentina Boni; Caroline Even; Jerome Fayette; Maria José Flor; Kevin Harrington; Sung-Bae Kim; Lisa Licitra; Ioanna Nixon; Nabil F Saba; Stephan Hackenberg; Pol Specenier; Francis Worden; Binaifer Balsara; Mollie Leoni; Bridget Martell; Catherine Scholz; Antonio Gualberto
Journal:  J Clin Oncol       Date:  2021-03-22       Impact factor: 50.717

3.  Identification of a Costimulatory Molecule Gene Signature to Predict Survival and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma.

Authors:  Ling Aye; Xiaole Song; Jingyi Yang; Li Hu; Xicai Sun; Jiaying Zhou; Quan Liu; Hongmeng Yu; Dehui Wang
Journal:  Front Cell Dev Biol       Date:  2021-08-09

4.  Evaluation of Deep Learning to Augment Image-Guided Radiotherapy for Head and Neck and Prostate Cancers.

Authors:  Ozan Oktay; Jay Nanavati; Anton Schwaighofer; David Carter; Melissa Bristow; Ryutaro Tanno; Rajesh Jena; Gill Barnett; David Noble; Yvonne Rimmer; Ben Glocker; Kenton O'Hara; Christopher Bishop; Javier Alvarez-Valle; Aditya Nori
Journal:  JAMA Netw Open       Date:  2020-11-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.